| Literature DB >> 33592065 |
Mathieu Sikorski1, Flora Coulon1, Cécile Peltier1, Cécile Braudeau1,2, Alexandra Garcia1, Matthieu Giraud1, Karine Renaudin1,3, Christine Kandel-Aznar3, Steven Nedellec4, Philippe Hulin4, Julien Branchereau1,5,6, Joëlle Véziers7,8,9,10, Pauline Gaboriaud11, Antoine Touzé11, Julien Burlaud-Gaillard12, Régis Josien1,2, Dorian McIlroy1, Céline Bressollette-Bodin1,13, Franck Halary1.
Abstract
The BK polyomavirus (BKPyV) is a ubiquitous human virus that persists in the renourinary epithelium. Immunosuppression can lead to BKPyV reactivation in the first year post-transplantation in kidney transplant recipients (KTRs) and hematopoietic stem cell transplant recipients. In KTRs, persistent DNAemia has been correlated to the occurrence of polyomavirus-associated nephropathy (PVAN) that can lead to graft loss if not properly controlled. Based on recent observations that conventional dendritic cells (cDCs) specifically infiltrate PVAN lesions, we hypothesized that those cells could play a role in BKPyV infection. We first demonstrated that monocyte-derived dendritic cells (MDDCs), an in vitro model for mDCs, captured BKPyV particles through an unconventional GRAF-1 endocytic pathway. Neither BKPyV particles nor BKPyV-infected cells were shown to activate MDDCs. Endocytosed virions were efficiently transmitted to permissive cells and protected from the antibody-mediated neutralization. Finally, we demonstrated that freshly isolated CD1c+ mDCs from the blood and kidney parenchyma behaved similarly to MDDCs thus extending our results to cells of clinical relevance. This study sheds light on a potential unprecedented CD1c+ mDC involvement in the BKPyV infection as a promoter of viral spreading.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33592065 PMCID: PMC7886149 DOI: 10.1371/journal.ppat.1009042
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823